CTRI/2019/09/021436尚未招募2 期
A Prospective Study Comparing Induction Chemotherapy Followed By Chemoradiation Versus Chemoradiation Alone In Stage III Non Small Cell Lung Cancer
sskm radiotherapy department0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •non small cell lung cancer ecog 2
排除标准
- •small cell lung cancer co morbidities
研究者
相似试验
已完成
3 期
Comparative Study of Treatment Outcome in the Patients suffering from Locally Advanced Esophageal Cancers without any distant metastasis, treated with either Chemotherapy followed by Radiotherapy or Chemotherapy and Radiotherapy Simultaneously.CTRI/2018/05/013773IPGMER Fluid Research Fund40
已完成
2 期
Evaluation of treatment outcome of induction chemotherapy and then Neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancerIRCT20200420047139N1Shahid Beheshti University of Medical Sciences30
进行中（未招募）
1 期
Comparison of two treatment arms of patients with non-small cell lung cancer. Patients of one arm receive the authorized infusion Durvalumab after chemotherapy, chemotherapy with radiotherapy and optional resection. Patients in the second treatment arm receive Durvalumab from the beginning, in parallel with standard therapy.non-small cell lung cancer stages IIIA (N2) and selected resectable stages IIIBMedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-000058-77-DEniversity Hospital Essen90
进行中（未招募）
1 期
A multi-centre randomised phase II study with a safety run-in of induction chemotherapy followed by capecitabine with or without nelfinavir with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer.EUCTR2013-004968-56-GBniversity of Oxford Clinical Trials & Research Governance196
未知
2 期
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.JPRN-C000000358Fukushima Medical University25